NHS (BM)

The Bailenese National Health Service is a collective of publicly funded nationalised healthcare facilities in Baileneu Ma, managing the production, distribution, licensing and administration of pharmaceutical drugs and other health related services such as dentistry, surgery and addiction clinics. Founded in 1998, the NHS is run separately to the government in order to reduce corruption and political criticism, its most notable project was TropDEP, a project carried out by the SWP utilising the NHS, which led to the near eradication of several diseases such as, and  through vaccination and effective quarantining.

Prosthetic Genetic Research
As part of a broader ECOSEAS research, Bailenese scientists under the NHS Experimental Research Team have co-developed synthetic DNA, nicknamed XNA (Xeno-Nucleic Acid), where it has been shown to complimentary with DNA and RNA, opening up a new path of research towards treatment of cancer and genetic diseases. The development of XNA has also led to the creation of X-enzymes, which due to its high stability in comparison to other natural polynucleotides (RNA and DNA), have been suggested for use against certain viral infections, largely retrovirals such as HIV and Hepatitis B. It is thought that as this early research begins to develop into a larger project, the concept of synthetic life and artificially extended lifetimes are on the horizon.

Products
The NHS produces many pharmaceuticals for use in Baileneu Ma and exports, including anti-depressants, anti-convulsives, anti-malarials, painkillers and many more. Many of the products are geared towards the civilian market, although some medications are made for military and civilian applications. Bailenese anti-depressants are often sought as an alternative to more conventional medications, due to their largely harmless side-effects, low toxicity and unorthodox effects, which can be used to treat a host of different psychological disorders. Serotonin antagonists are also prescribed in conjunction with anti-depressants in order to prevent overdoses and serotonin syndrome, Telenozine and Cyproheptadine are typically used in small amounts.

Antibiotics

 * 'Sativane' SP cannabinoid based antibiotic for use against antibiotic resistant bacteria
 * 'Bunitere' HP Polymyxin B antibiotic for use on gram negative antibiotic resistant bacteria
 * 'Vicidinere' HP Vancomycin antibiotic useful against MRSA

Analgesics and Anaesthetics

 * 'Telenozine' HP methysergide based medication, rarely used migraine and cluster headache treatment due to potential side-effects
 * 'Aldacrozine' SP used in treatment for cluster headaches, can be used alongside glaucoma
 * 'Butastrel' SP aspirin based, light analgesic medication
 * 'Helexane' SP cannabinoid derivative with some nausea and inflammatory/neuropathic pain easing effects
 * 'Diprosac' SP opioid based, light prescription-analgesic comprised of tapentadol, oxycodone, hydrocodone, ibuprofen and acetaminophen. The ratio of mixtures varies depending on the type of Diprosac being prescriped, with extended release versions being available. Higher dosage Diprosac pills are also pressed with naloxone to relief potentially harmful side-effects and prevent overdose
 * 'Numinosac' SP opioid based stronger prescription analgesic, used in treatment for severe pain and as a cough suppressant, made up of dihydrocodeine and racemorphan. Due to high potential for abuse, it cannot be prescribed for any longer than 4 weeks in order to avoid withdrawal and addiction.

Anti-Depressants

 * 'Effizapryn' SP can be used as a prescription anti-depressant in treatment for OCD and depression, as well as in treatment for cluster headaches and glaucoma
 * 'Meprosyn' SP can be used in small doses as a prescription anti-depressant and in higher doses for therapy
 * 'Ginapryn' SP can be administered in low doses for treatment for PTSD and depression
 * 'Indopryn' HP rarely used strong anti-depressant in treatment of anxiety, ADHD and depression
 * 'Trandopryn' HP prescription anti-depressant, useful for treating bipolar disorder
 * 'Brodenozine' SP used as both anti-depressant and anxiolytic, as well as treatment for addiction
 * 'Adexane' SP cannabinoid derivative used for treatment in anxiety and depression alongside other medications
 * 'Insopac' SP can be issued in conjunction or solely as treatment for depression and other serotonin deficiencies
 * 'Ghenotin' SP arylcyclohexylamine based anti-depressant recently introduced
 * 'Julimonem' SP iboga extract used for treatment of depression and alcoholism
 * 'Navedol' HP licensed sertraline, can only be combined with other medications with the judgement of a doctor
 * 'Choroprofen' HP MAO inhibitor, tranylcypromine derivative, should only be used under special solicitation
 * 'Olsanem' HP TeCA anti-depressant based on maprotiline, shouldn't be combined with other medications

Antipsychotics

 * 'Univatin' SP mixture of Olanzapine and Midazolam, typically used in treatment of schizophrenia, schizoaffective disorders and other psychotic mental illnesses, typically used to relieve agitation
 * 'Kerataxin' SP Ziprasidone, Trandopryn and Estazolam mixture useful for treating Bipolar Disorders, Psychotic Depression and Schizoaffective Disorders

Sedatives, Hypnotics and Anxiolytics

 * 'Declorall' SP mixture of Eszopiclone and Indiplon given in 8 and 12 mg doses with extended release features, used primarily in treatment for insomnia
 * 'Theminall' SP Ocinaplon-based weak anxiolytic that is rarely used due to liver complications in some subjects
 * 'Hunijall' SP mixture of Suriclone, Pazinaclone and Pagoclone used as an anxiolytic with very limited sedative side-effects
 * 'Fluxitall' HP powerful anxiolytic and anti-depressant SSRI with limited anti-convulsant and sedative uses, 30-70 mixture of Viqualine and Pipequaline
 * 'Herpredinex' SP powerful benzodiazepine (Loprazolam) sedative used in treatment for severe insomnia
 * 'Muniplex' SP anti-convulsant and anxiolytic used in treatment for epilepsy primarily, mixture of clobazam, clonazepam and lormetazepam
 * 'Chromevirane' SP cannabinoid based anti-convulsant effective against brain cancer and epilepsy-related seizures

Anti-Histamines

 * 'Betipreze' SP quifenadine antihistamine
 * 'Alopreze' SP latrepirdine antihistamine
 * 'Diazepreze' HP diphenhydramine antihistamine used primarily in hospitals for severe allergic reactions

Antineoplastics

 * 'Ceredocin' HP vincristine derivative used in leukemia treatment
 * 'Valnone' HP mitomycin based medication for use various cancer treatments
 * 'Yulixane' SP cannabinoid based medication that can inhibit the growth of a tumour, improve apoptosis and ease Alzheimers, Parkinsons and Huntington's disease

Antimalarials

 * 'Abrinez' HP outdated quinine based antimalarial
 * 'Vorinez' HP modern hydroxychloroquine used in treatment for malaria, lupus and rheumatoid arthritis

Antiparkinson

 * 'Levozine' HP commonly used antiparkinson agent, can also be used to prevent migraine attacks
 * 'Tratodazamine' HP licensed version of selegiline, can be used as an antiparkinson agent, and treatment for depression, ADHD and dementia

Vaccines

 * 'Bebin-012-NPV' vaccine for Nipah Virus
 * 'Bebin-221-OHV' vaccine for Neffeje-Orthohantovirus
 * 'Bebin-202-OHV' vaccine for Jollo-Orthohantovirus
 * 'Bebin-349-MMV' vaccine for Marasmavirus

Analgesics and Anaesthetics

 * 'ALM-005' Arylcyclohexylamine analgesic used as primary painkiller in the Bailenese People's Army as it's effects are less potent than other powerful painkillers and does not cause respiratory depression. It is typically given to most members of a combat patrol and administered through intramuscular auto-injectors, effects include dissociation, analgesia, anesthesia and sedation.
 * 'ALM-012' synthetic opiate analgesic used as a more potent painkiller in the Bailenese People's Army
 * 'ALM-023' Arylcyclohexylamine with dissociating and analgesic effects combined with clobazam for extreme analgesic effects in medical evacuations, used by Bailenese People's Army

Upcoming

 * 'Nufidotal' an experimental anxiolytic, antipsychotic and antidepressant that is in Stage III of trials, currently being used in experimental treatment of extreme mental health conditions